Edition:
United States

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

11.37USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$11.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,556
52-wk High
$38.68
52-wk Low
$6.99

Select another date:

Wed, May 9 2018

BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72

* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted

* MENLO THERAPEUTICS - CO'S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT

BRIEF-Menlo Therapeutics Reports Q4 Loss Of $1.80 Per Share

* MENLO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: